6o41

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
<StructureSection load='6o41' size='340' side='right'caption='[[6o41]], [[Resolution|resolution]] 2.46&Aring;' scene=''>
<StructureSection load='6o41' size='340' side='right'caption='[[6o41]], [[Resolution|resolution]] 2.46&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[6o41]] is a 9 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6O41 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6O41 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[6o41]] is a 9 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human] and [http://en.wikipedia.org/wiki/Strsg Strsg]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6O41 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6O41 FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6o3d|6o3d]], [[6o3g|6o3g]], [[6o3j|6o3j]], [[6o3k|6o3k]], [[6o3l|6o3l]], [[6o3u|6o3u]], [[6o42|6o42]]</td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6o3d|6o3d]], [[6o3g|6o3g]], [[6o3j|6o3j]], [[6o3k|6o3k]], [[6o3l|6o3l]], [[6o3u|6o3u]], [[6o42|6o42]]</td></tr>
 +
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">spg ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1320 STRSG])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6o41 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6o41 OCA], [http://pdbe.org/6o41 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6o41 RCSB], [http://www.ebi.ac.uk/pdbsum/6o41 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6o41 ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6o41 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6o41 OCA], [http://pdbe.org/6o41 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6o41 RCSB], [http://www.ebi.ac.uk/pdbsum/6o41 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6o41 ProSAT]</span></td></tr>
</table>
</table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
The membrane-proximal external region (MPER) of HIV-1 envelope glycoprotein (Env) can be targeted by neutralizing antibodies of exceptional breadth. MPER antibodies usually have long, hydrophobic CDRH3s, lack activity as inferred germline precursors, are often from the minor IgG3 subclass, and some are polyreactive, such as 4E10. Here we describe an MPER broadly neutralizing antibody from the major IgG1 subclass, PGZL1, which shares germline V/D-region genes with 4E10, has a shorter CDRH3, and is less polyreactive. A recombinant sublineage variant pan-neutralizes a 130-isolate panel at 1.4 mug/ml (IC50). Notably, a germline revertant with mature CDR3s neutralizes 12% of viruses and still binds MPER after DJ reversion. Crystal structures of lipid-bound PGZL1 variants and cryo-EM reconstruction of an Env-PGZL1 complex reveal how these antibodies recognize MPER and viral membrane. Discovery of common genetic and structural elements among MPER antibodies from different patients suggests that such antibodies could be elicited using carefully designed immunogens.
 +
 +
An MPER antibody neutralizes HIV-1 using germline features shared among donors.,Zhang L, Irimia A, He L, Landais E, Rantalainen K, Leaman DP, Vollbrecht T, Stano A, Sands DI, Kim AS, Poignard P, Burton DR, Murrell B, Ward AB, Zhu J, Wilson IA, Zwick MB Nat Commun. 2019 Nov 26;10(1):5389. doi: 10.1038/s41467-019-12973-1. PMID:31772165<ref>PMID:31772165</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 6o41" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
 +
[[Category: Human]]
[[Category: Large Structures]]
[[Category: Large Structures]]
 +
[[Category: Strsg]]
[[Category: Irimia, A]]
[[Category: Irimia, A]]
[[Category: Wilson, I A]]
[[Category: Wilson, I A]]

Revision as of 18:41, 11 December 2019

Crystal structure of the unbound PGZL1 germline Fab fragment (PGZL1_gVmDmJ)

PDB ID 6o41

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools